Skip to main content

Stonepine Capital Management, LLC

Source: SEC Form 13F · as of Mar 2026

Stonepine Capital Management, LLC holds 37 biotech & pharma companies tracked by BioSniper, totaling $70.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

37

Total value held

$70.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for TENAX THERAPEUTICS, INC. (TENX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
TENXTENAX THERAPEUTICS, INC.975,200$15.6M
ADMAADMA BIOLOGICS, INC.740,000$6.7M
CAMPCamp4 Therapeutics Corp1,389,622$6.1M
NKTRNEKTAR THERAPEUTICS85,000$6.1M
ZVRAZEVRA THERAPEUTICS, INC.480,000$4.5M
CRBPCorbus Pharmaceuticals Holdings, Inc.383,462$3.6M
ABEOABEONA THERAPEUTICS INC.746,587$3.3M
KZIAKAZIA THERAPEUTICS LTD345,179$2.6M
ANTXAN2 Therapeutics, Inc.713,845$2.4M
XOMAXOMA Royalty Corporation69,500$2.2M
AYTUAYTU BIOPHARMA, INC792,289$2.2M
CBIOCRESCENT BIOPHARMA, INC.85,000$1.6M
ACETAdicet Bio, Inc.221,955$1.5M
XFORX4 Pharmaceuticals, Inc335,309$1.4M
HRTXHERON THERAPEUTICS, INC. /DE/1,402,191$1.1M
INABIN8BIO, INC.663,412$982K
SRZNSurrozen Inc.33,005$961K
CTMXCytomX Therapeutics, Inc.200,000$940K
BIOABioAge Labs, Inc.50,000$875K
RADXRadiopharm Theranostics Limited51,000,000$739K
ZNTLZentalis Pharmaceuticals, Inc.269,100$630K
KTTAPasithea Therapeutics Corp.831,301$617K
OKUROnKure Therapeutics, Inc.132,578$549K
CADLCandel Therapeutics, Inc.102,500$502K
QNRXQuoin Pharmaceuticals, Ltd.53,460$353K
UPBUpstream Bio, Inc.35,000$315K
IRDOpus Genetics, Inc.68,688$313K
ARVNARVINAS, INC.27,500$292K
PLRXPLIANT THERAPEUTICS, INC.224,650$283K
XERSXeris Biopharma Holdings, Inc.40,030$232K
SABSSAB BIOTHERAPEUTICS, INC.50,000$192K
EDSAEdesa Biotech, Inc.30,000$157K
PCSAProcessa Pharmaceuticals, Inc.55,000$139K
KLRSKalaris Therapeutics, Inc.20,400$118K
OVIDOvid Therapeutics Inc.40,000$89K
EVAXEvaxion A/S19,713$73K
BCABBioAtla, Inc.65,387$11K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.